GlaxoSmithKline Pakistan Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline Pakistan Limited with three other
companies in this sector in Pakistan:
Abbott Laboratories (Pakistan) Ltd
sales of 29.72 billion Pakistan Rupees [US$209.82 million]
of which 74%
Glaxosmithkline Consumer Healthcare Pakistan Ltd
(14.88 billion Pakistan Rupees [US$105.02 million]
Searle Co Ltd
(16.40 billion Pakistan Rupees [US$115.75 million]
of which 84%
During the year ended December of 2018, sales at
GlaxoSmithKline Pakistan Limited were 34.01 billion Pakistan Rupees (US$240.09 million).
increase of 3.8%
versus 2017, when the company's sales were 32.77 billion Pakistan Rupees.
This was the third consecutive year of growth at GlaxoSmithKline Pakistan Limited.